Plus Therapeutics, Inc. · NASDAQ:PSTV
Sims Andrew John Hugh MacIntyre exercised options for 2,985 Plus Therapeutics, Inc. shares (Form 4)
Traded Jul 1, 2026 · Filed Jul 1, 2026
On Jul 1, 2026, Sims Andrew John Hugh MacIntyre (Chief Financial Officer) exercised options for 2,985 Plus Therapeutics, Inc. shares, leaving 9,941 shares. Filed Jul 1, 2026 (Form 4).
- Options exercised
- 2,985 shares
- Holding after
- 9,941 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Option exercise | 1,533 | 8,489 | Direct | |
| Jul 1, 2026 | Common Stock | Option exercise | 1,165 | 9,654 | Direct | |
| Jul 1, 2026 | Common Stock | Option exercise | 287 | 9,941 | Direct |
Source
Related
- Plus Therapeutics, Inc.
- Sims Andrew John Hugh MacIntyre
- Plus Therapeutics, Inc. shareholders
- Form 4 · Sims Andrew John Hugh MacIntyre · Apr 1, 2026
- Form 4 · Andrews Ronald Asbury · Jul 1, 2026
- Form 4 · Hawkins Richard J · Jul 1, 2026
- Form 4 · Guse Kyle · Jul 1, 2026
- Form 4 · van Es-Johansson An · Jul 1, 2026
- Form 4 · Hedrick Marc H · Jul 1, 2026